Bruker Corporation acquired 97.15% stake in Biognosys AG for CHF 75 million.
Bruker Corporation (NasdaqGS:BRKR) completed the acquisition 97.15% stake in Biognosys AG on January 3, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.09 USD | -3.26% |
|
+4.64% | -12.78% |
1st Jan change | Capi. | |
---|---|---|
-12.78% | 10.03B | |
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+33.90% | 115B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B |